Schedule 13 Transitional provisions relating to EU ExitF1

1. 1List of countries for the purpose of the definition of “marketing authorization” on IP completion day (regulation 2A)
2. 2List of countries where a sponsor of a clinical trial, or their legal representative, may be established on IP completion day (regulation 3(11A))
3. 3Import of investigational medicinal products into Great Britain from EEA States during the transitional period
4. 4Approved country for import list on IP completion day (regulation 43A)